CIII nasal spray, marking the first monotherapy to be approved for adults with treatment-resistant depression (TRD).

After getting a metastatic breast cancer diagnosis, you may experience anxiety and depression. Here are some ways to manage ...

Medically reviewed by Akeem Marsh, MD We often think of temper tantrums as something that kids outgrow after the toddler ...

The best time to take a magnesium supplement depends on several factors, including the type it contains and the condition it ...

Commonly used diabetes drugs could lower the risk of cardiometabolic conditions but heighten the risk of gastrointestinal and ...

A multidisciplinary approach, including ketamine withdrawal and symptom management, is essential to mitigate long-term ...

Despite conflicting data regarding the pharmacological management of Borderline Personality Disorder (BPD), a recent ...

While the fruit has many benefits, avoid eating it to prevent putting your health at risk if you take the medication ...

Millions of Brits are being warned to avoid a specific fruit, and there's an important reason behind this advice. Figures ...

Dear Savvy Senior, My dad has always been a pack rat, but since mom died a few years ago he’s become more of a hoarder. The ...

Johnson & Johnson (NYSE: JNJ) announced today the U.S. Food and Drug Administration (FDA) approval of a supplemental New Drug Application (sNDA) for SPRAVATO® (esketamine) CIII nasal spray, making ...